← Leaderboards
Robert Hoover
Cancer Epidemiology And Genetics
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Cancer Epidemiology And Genetics
Same institution · by research overlap
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsCohortMalignant Neoplasm Of ProstateCancer RiskFollow-UpCollaborationsQuestionnairesMalignant Breast NeoplasmRisk FactorsResearch PersonnelCategoriesMalignant Neoplasm Of LungMalignant Neoplasm Of OvaryColorectal CancerCancer GeneticsMedical RecordsGenome Wide Association StudyGeneticLaboratoriesCessation Of LifeReproductiveMalignant Neoplasm Of Urinary BladderBreastPrevention
Grant awards (73)
Cohort and Biobank Development$5,689,329
ZIC · FY2019 · CA · contact PI
Early Life Exposures and Subsequent Cancer Risk$1,566,550
ZIA · FY2019 · CA · contact PI
PLCO Trial Etiologic and Early Marker Study$1,029,651
ZIA · FY2019 · CA · contact PI
General Studies of Epidemiology$133,537
ZIA · FY2019 · CA · contact PI
Cancer Genetic Markers of Susceptibility$107,959
ZIA · FY2019 · CA · contact PI
PLCO EEMS and Extended Follow Up$20,552
ZIA · FY2019 · CA · contact PI
PLCO EEMS and Extended Follow Up$2,743,757
ZIA · FY2018 · CA · contact PI
PLCO Trial Etiologic and Early Marker Study$2,359,239
ZIA · FY2018 · CA · contact PI
General Studies of Epidemiology$338,691
ZIA · FY2018 · CA · contact PI
Cancer Genetic Markers of Susceptibility$252,996
ZIA · FY2018 · CA · contact PI
PLCO EEMS and Extended Follow Up$800,895
ZIA · FY2017 · CA · contact PI
PLCO Trial Etiologic and Early Marker Study$736,077
ZIA · FY2017 · CA · contact PI
General Studies of Epidemiology$199,659
ZIA · FY2017 · CA · contact PI
Cancer Genetic Markers of Susceptibility$106,767
ZIA · FY2017 · CA · contact PI
PLCO Trial Etiologic and Early Marker Study$2,752,961
ZIA · FY2016 · CA · contact PI
Early Life Exposures and Subsequent Cancer Risk$2,752,232
ZIA · FY2016 · CA · contact PI
PLCO EEMS and Extended Follow Up$706,495
ZIA · FY2016 · CA · contact PI
Cohort and Biobank Development$223,301
ZIC · FY2016 · CA · contact PI
General Studies of Epidemiology$188,507
ZIA · FY2016 · CA · contact PI
Cancer Genetic Markers of Susceptibility$169,781
ZIA · FY2016 · CA · contact PI
Early Life Exposures and Subsequent Cancer Risk$2,988,090
ZIA · FY2015 · CA · contact PI
PLCO Trial Etiologic and Early Marker Study$2,139,074
ZIA · FY2015 · CA · contact PI
PLCO EEMS and Extended Follow Up$664,206
ZIA · FY2015 · CA · contact PI
Cohort and Biobank Development$299,176
ZIC · FY2015 · CA · contact PI
General Studies of Epidemiology$231,939
ZIA · FY2015 · CA · contact PI
Cancer Genetic Markers of Susceptibility$118,607
ZIA · FY2015 · CA · contact PI
Early Life Exposures and Subsequent Cancer Risk$3,964,643
ZIA · FY2014 · CA · contact PI
PLCO Trial Etiologic and Early Marker Study$2,195,827
ZIA · FY2014 · CA · contact PI
PLCO EEMS and Extended Follow Up$979,773
ZIA · FY2014 · CA · contact PI
Cohort and Biobank Development$231,071
ZIC · FY2014 · CA · contact PI
Cancer Genetic Markers of Susceptibility$175,804
ZIA · FY2014 · CA · contact PI
General Studies of Epidemiology$99,063
ZIA · FY2014 · CA · contact PI
Early Life Exposures and Subsequent Cancer Risk$3,540,683
ZIA · FY2013 · CA · contact PI
PLCO Trial Etiologic and Early Marker Study$1,915,866
ZIA · FY2013 · CA · contact PI
PLCO EEMS and Extended Follow Up$761,919
ZIA · FY2013 · CA · contact PI
Cancer Genetic Markers of Susceptibility$186,238
ZIA · FY2013 · CA · contact PI
General Studies of Epidemiology$158,326
ZIA · FY2013 · CA · contact PI
Early Life Exposures and Subsequent Cancer Risk$3,741,794
ZIA · FY2012 · CA · contact PI
PLCO Trial Etiologic and Early Marker Study$2,050,613
ZIA · FY2012 · CA · contact PI
PLCO EEMS and Extended Follow Up$840,647
ZIA · FY2012 · CA · contact PI
Cancer Genetic Markers of Susceptibility$269,589
ZIA · FY2012 · CA · contact PI
General Studies of Epidemiology$208,499
ZIA · FY2012 · CA · contact PI
Early Life Exposures and Subsequent Cancer Risk$1,561,986
ZIA · FY2011 · CA · contact PI
PLCO EEMS and Extended Follow Up$1,359,323
ZIA · FY2011 · CA · contact PI
Cancer Genetic Markers of Susceptibility$808,923
ZIA · FY2011 · CA · contact PI
General Studies of Epidemiology$800,436
ZIA · FY2011 · CA · contact PI
Early Life Exposures and Subsequent Cancer Risk$2,260,493
ZIA · FY2010 · CA · contact PI
PLCO EEMS and Extended Follow Up$301,917
ZIA · FY2010 · CA · contact PI
General Studies of Epidemiology$146,924
ZIA · FY2010 · CA · contact PI
Cancer Genetic Markers of Susceptibility$101,693
ZIA · FY2010 · CA · contact PI
General Studies of Epidemiology$1,179,864
ZIA · FY2009 · CA · contact PI
Early Life Exposures and Subsequent Cancer Risk$1,158,639
ZIA · FY2009 · CA · contact PI
Cancer Genetic Markers of Susceptibility$398,548
ZIA · FY2009 · CA · contact PI
CGEMS$522,757
Z01 · FY2008 · CA · contact PI
Early Life Exposures and Subsequent Cancer Risk$500,700
Z01 · FY2008 · CA · contact PI
General Studies of Epidemiology$309,198
Z01 · FY2008 · CA · contact PI
General Studies of Epidemiology$349,088
Z01 · FY2007 · CA · contact PI
CGEMS$260,559
Z01 · FY2007 · CA · contact PI
Early Life Exposures and Subsequent Cancer Risk$158,274
Z01 · FY2007 · CA · contact PI
Early Life Exposures and Subsequent Cancer Risk$0
Z01 · FY2006 · CP · contact PI
General Studies of Epidemiology$0
Z01 · FY2006 · CP · contact PI
CGEMS$0
Z01 · FY2006 · CP · contact PI
Early Life Exposures and Subsequent Cancer Risk$0
Z01 · FY2005 · CP
CGEMS$0
Z01 · FY2005 · CP
General Studies of Epidemiology$0
Z01 · FY2005 · CP
Early Life Exposures and Subsequent Cancer Ri$0
Z01 · FY2004 · CP
General Studies of Epidemiology$0
Z01 · FY2004 · CP
Early Life Exposures and Subsequent Cancer Risk$0
Z01 · FY2003 · CP
General Studies of Epidemiology$0
Z01 · FY2003 · CP
Early Life Exposures and Subsequent Cancer Risk$0
Z01 · FY2002 · CP
Studies of Osteosarcoma$0
Z01 · FY2002 · CP
Early Life Exposures and Subsequent Cancer Risk$0
Z01 · FY2001 · CP
Studies of Osteosarcoma$0
Z01 · FY2001 · CP